GABAergic modulation in the substantia nigra of the striatal dopamine release and of the locomotor activity in rats exposed to helium pressure

被引:5
作者
Balon, N
Kriem, B
Weiss, M
Rostain, JC
机构
[1] Univ Mediterranee, Lab Physiopathol & Act Therapeut Gaz Press, Fac Med Nord, IFR Jean Roche, F-13916 Marseille 20, France
[2] IMNSSA, Lab Physiopathol & Act Therapeut Gaz Press, Fac Med Nord, IFR Jean Roche, F-13916 Marseille, France
[3] Univ Nancy 1, UFR STAPS, Lab Neurochim Fonct & Neuropharmacol, Fac Sci, F-54506 Vandoeuvre Les Nancy, France
关键词
Baclofen; basal ganglia; high pressure nervous syndrome; muscimol; locomotor and motor activity; voltammetry;
D O I
10.1016/S0006-8993(02)02952-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Helium-oxygen pressure induces in rodents an increase of both locomotor and motor activity (LMA) and of the striatal dopamine release, which could result from a decrease of GABA transmission in the substantia nigra. The effects of the GABA(A) receptor agonist muscimol and of the GABA(B) receptor agonist baclofen on the striatal dopamine release were measured using differential pulse voltammetry. Behavioural studies were performed in freely moving rats using actimetry. Whatever the drug used under helium pressure, bilateral administration in the substantia nigra pars reticulata (SNr) or in the substantia nigra pars compacta (SNc) counteracted the evoked dopamine release. However, only the baclofen reduced the LMA, while the muscimol administration in the SNr, but not in the SNc, increased it. These results indicate that different subtypes of GABA receptors would be involved in the control of the DA release and in the occurrence of LMA under helium pressure. (C) 2002 Elsevier Science BY All rights reserved.
引用
收藏
页码:82 / 92
页数:11
相关论文
共 35 条
[1]   PRESSURE-INDUCED STRIATAL DOPAMINE RELEASE CORRELATES HYPERLOCOMOTOR ACTIVITY IN RATS EXPOSED TO HIGH-PRESSURE [J].
ABRAINI, JH ;
ROSTAIN, JC .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 71 (02) :638-643
[2]   ROLE OF DOPAMINE-RECEPTORS IN THE OCCURRENCE OF THE BEHAVIORAL MOTOR DISTURBANCES IN RATS EXPOSED TO HIGH-PRESSURE [J].
ABRAINI, JH ;
TOMEI, C ;
ROSTAIN, JC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (03) :773-779
[3]   PRESSURE REVERSED EXTRACELLULAR STRIATAL DOPAMINE DECREASE PRODUCED BY D(1)-RECEPTOR AGONIST SKF-38393, AND D(2)-RECEPTOR AGONIST LY-171555, BUT FAILED TO CHANGE THE EFFECT OF THE ACTIVATION OF BOTH D(1)-RECEPTOR AND D(2)-RECEPTOR [J].
ABRAINI, JH ;
FECHTALI, T ;
ROSTAIN, JC .
NEUROSCIENCE, 1992, 50 (02) :395-402
[4]   DRUGS THAT INCREASE GAMMA-AMINOBUTYRIC ACID TRANSMISSION PROTECT AGAINST THE HIGH-PRESSURE NEUROLOGICAL SYNDROME [J].
BICHARD, AR ;
LITTLE, HJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1982, 76 (03) :447-452
[5]   Synaptic organisation of the basal ganglia [J].
Bolam, JP ;
Hanley, JJ ;
Booth, PAC ;
Bevan, MD .
JOURNAL OF ANATOMY, 2000, 196 :527-542
[6]   Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake [J].
Chan, PKY ;
Yung, WH .
BRAIN RESEARCH, 1999, 838 (1-2) :18-26
[7]   The full expression of locomotor and motor hyperactivities induced by pressure requires both striatal dopaminergic and N-methyl-D-asparate receptor activities in the rat [J].
Darbin, O ;
Risso, JJ ;
Rostain, JC .
NEUROSCIENCE LETTERS, 1999, 267 (03) :149-152
[8]   A new system analysis of motor and locomotor activities associated with a microdialysis study of pressure-induced dopamine increase in rats [J].
Darbin, O ;
Risso, JJ ;
Rostain, JC .
PHYSIOLOGY & BEHAVIOR, 1997, 62 (02) :367-371
[9]   INVITRO AND INVIVO CHARACTERIZATION OF THE PROPERTIES OF A MULTIFIBER CARBON ELECTRODE ALLOWING LONG-TERM ELECTROCHEMICAL DETECTION OF DOPAMINE IN FREELY MOVING ANIMALS [J].
ELGANOUNI, S ;
FORNI, C ;
NIEOULLON, A .
BRAIN RESEARCH, 1987, 404 (1-2) :239-256
[10]   Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by γ-hydroxybutyric acid (GHBA) are specifically induced by activation of GABAB receptors [J].
Erhardt, S ;
Andersson, B ;
Nissbrandt, H ;
Engberg, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (06) :611-619